• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Anthogyr AXIOM IMPLANT X3 ?3.4 x 12.0; Endosseous Dental Implant

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Anthogyr AXIOM IMPLANT X3 ?3.4 x 12.0; Endosseous Dental Implant Back to Search Results
Catalog Number XT34120
Medical Device Problem Code Failure to Osseointegrate (1863)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/11/2026
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth.Details of surgery: primary stability not achieved.On (b)(6) 2026, non-osseointegration was verified.The device was forwarded to the manufacturer.There were no reported patient injuries or complications.
 
Additional Manufacturer Narrative
The batch number could not be verified due to incomplete or missing information and / or product from the customer.Our manufacturing q-system assures that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.The non-integration of an endosseous dental implant during the healing phase is a known inherent risk of the treatment with dental implants.Most implant failures occur before occlusal loading (analainen et al.2013, koldsland et al.2009).Based on clinical studies about 1-3% of the implants fail within the first year after implantation (ganeles et al.2008).Implants may have to be removed in case one or more of the implants success criteria are not met.Implant success criteria according to buser et al.(1991) are: 1.Absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia.2.Absence of a recurrent peri-implant infection with suppuration.3.Absence of implant mobility.4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported early failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOM IMPLANT X3 ?3.4 x 12.0
Common Device Name
Endosseous Dental Implant
Manufacturer (Section D)
Anthogyr
2237, avenue andr?-lasquin
sallanches 74700
FR  74700
Manufacturer (Section G)
Anthogyr
2237, avenue andr?-lasquin
sallanches 74700
FR   74700
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
+1(978)747-2509
MDR Report Key50281587
Report Number0008020776-2026-000897
Device Sequence Number18659083
Product Code DZE
UDI-Device Identifier03663394483490
UDI-Public03663394483490
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K230104
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 08/17/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberXT34120
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/24/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/17/2026
Initial Report FDA Received Date08/17/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age57 YR
Patient SexMale
-
-